Nanomaterials: a promising multimodal theranostics platform for thyroid cancer
Source abstract
Abstract
Thyroid cancer is the most prevalent malignant neoplasm of the cervical region and endocrine system, characterized by a discernible upward trend in incidence over recent years. Ultrasound-guided fine needle aspiration is the current standard for preoperative diagnosis of thyroid cancer, albeit with limitations and a certain degree of false-negative outcomes. Although differentiated thyroid carcinoma generally exhibits a favorable prognosis, dedifferentiation is associated with an unfavorable clinical course. Anaplastic thyroid cancer, characterized by high malignancy and aggressiveness, remains an unmet clinical need with no effective treatments available. The emergence of nanomedicine has opened new avenues for cancer theranostics. The unique features of nanomaterials, including multifunctionality, modifiability, and various detection modes, enable non-invasive and convenient thyroid cancer diagnosis through multimodal imaging. For thyroid cancer treatment, nanomaterial-based photothermal therapy or photodynamic therapy, combined with chemotherapy, radiotherapy, or gene therapy, holds promise in reducing invasiveness and prolonging patient survival or alleviating pain in individuals with anaplastic thyroid carcinoma. Furthermore, nanomaterials enable simultaneous diagnosis and treatment of thyroid cancer. This review aims to provide a comprehensive survey of the latest developments in nanomaterials for thyroid cancer diagnosis and treatment and encourage further research in developing innovative and effective theranostic approaches for thyroid cancer.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Thyroid Cancer Diagnosis and Treatment · Nanoplatforms for cancer theranostics · S100 Proteins and Annexins
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, 130012, P. R. China
Department of Endocrinology, Lequn Branch, The First Hospital of Jilin University, Changchun, 130031, China
References (100+)
Show source-provided references
1. Sanabria · Head Neck · 2018 · 40 · 85510.1002/hed.25029 ↗
2. Pellegriti · J. Cancer Epidemiol. · 2013 · 2013 · 96521210.1155/2013/965212 ↗
3. Seib · Endocrinol. Metab. Clin. North Am. · 2019 · 48 · 2310.1016/j.ecl.2018.10.002 ↗
4. Kim · Eur. J. Nutr. · 2017 · 56 · 96510.1007/s00394-015-1144-2 ↗
5. Lim · JAMA · 2017 · 317 · 133810.1001/jama.2017.2719 ↗
6. Rahib · Cancer Res. · 2014 · 74 · 291310.1158/0008-5472.CAN-14-0155 ↗
7. Bauer · Endocr. Dev. · 2014 · 26 · 18310.1159/000363164 ↗
8. Borges · Rev. Saude Publica · 2019 · 53 · 10610.11606/S1518-8787.2019053001496 ↗
9. Wang · Thyroid · 2014 · 24 · 159410.1089/thy.2014.0173 ↗
10. Papaleontiou · J. Clin. Endocrinol. Metab. · 2017 · 102 · 254310.1210/jc.2017-00255 ↗
11. Abe · Histol. Histopathol. · 2021 · 36 · 239
12. Molinaro · Nat. Rev. Endocrinol. · 2017 · 13 · 64410.1038/nrendo.2017.76 ↗
13. Kebebew · Cancer · 2005 · 103 · 133010.1002/cncr.20936 ↗
14. Chodak · J. Urol. · 1986 · 135 · 95110.1016/S0022-5347(17)45935-0 ↗
15. Renshaw · Arch. Pathol. Lab. Med. · 2013 · 137 · 162710.5858/arpa.2012-0575-OA ↗
16. van der Meel · Nat. Nanotechnol. · 2019 · 14 · 100710.1038/s41565-019-0567-y ↗
17. Zhou · Medicine · 2021 · 100 · e2704410.1097/MD.0000000000027044 ↗
18. Babaei · Bioimpacts · 2014 · 4 · 15
19. Ijaz Dar · J. Mater. Chem. B · 2020 · 8 · 835610.1039/D0TB01526A ↗
20. Huang · ACS Nano · 2019 · 13 · 72810.1021/acsnano.8b08010 ↗
21. Zhang · J. Hematol. Oncol. · 2019 · 12 · 13710.1186/s13045-019-0833-3 ↗
22. Shen · J. Controlled Release · 2012 · 161 · 88410.1016/j.jconrel.2012.05.013 ↗
23. Ma · Adv. Healthcare Mater. · 2019 · 8 · e190066110.1002/adhm.201900661 ↗
24. Huang · Adv. Healthcare Mater. · 2021 · 10 · e200102910.1002/adhm.202001029 ↗
25. Malheiros · Cytopathology · 2018 · 29 · 40710.1111/cyt.12575 ↗
26. Medici · BMC Med. · 2016 · 14 · 1110.1186/s12916-016-0554-1 ↗
27. Cerutti · Clin. Cancer Res. · 2006 · 12 · 331110.1158/1078-0432.CCR-05-2226 ↗
28. Eilers · Cancer Cytopathol. · 2014 · 122 · 74510.1002/cncy.21440 ↗
29. Hahn · Anal. Bioanal. Chem. · 2011 · 399 · 310.1007/s00216-010-4207-5 ↗
30. Mariyam · Mini. Rev. Med. Chem. · 2018 · 18 · 43910.2174/1389557517666170512095151 ↗
31. Aghebati-Maleki · J. Cell. Physiol. · 2020 · 235 · 196210.1002/jcp.29126 ↗
32. Alphandéry · Int. J. Mol. Sci. · 2022 · 23 · 168310.3390/ijms23031683 ↗
33. Zhou · Endocrine · 2020 · 70 · 25610.1007/s12020-020-02441-y ↗
34. Lan · Front. Endocrinol. · 2020 · 11 · 4410.3389/fendo.2020.00044 ↗
35. Li · Curr. Pharm. Des. · 2017 · 23 · 5403
36. Guvener · Methods · 2017 · 130 · 410.1016/j.ymeth.2017.05.018 ↗
37. Vlaisavljevich · Theranostics · 2013 · 3 · 85110.7150/thno.6717 ↗
38. Zhou · Cancer Lett. · 2020 · 470 · 20410.1016/j.canlet.2019.11.034 ↗
39. Hu · Contrast Media Mol. Imaging · 2018 · 2018 · 871086210.1155/2018/8710862 ↗
40. Fan · Contrast Media Mol. Imaging · 2022 · 2022 · 326534210.1155/2022/3265342 ↗
41. Xie · J. Ultrasound Med. · 2022 · 41 · 278910.1002/jum.15967 ↗
42. Hoang · Cancer Imaging · 2013 · 13 · 12810.1102/1470-7330.2013.0013 ↗
43. Myrissa · Acta Biomater. · 2017 · 48 · 52110.1016/j.actbio.2016.11.024 ↗
44. Hoang · J. Am. Coll. Radiol. · 2015 · 12 · 14310.1016/j.jacr.2014.09.038 ↗
45. Lee · Korean J. Radiol. · 2021 · 22 · 84010.3348/kjr.2020.0578 ↗
46. Xie · Theranostics · 2018 · 8 · 328410.7150/thno.25220 ↗
47. Avasthi · Top Curr. Chem. · 2020 · 378 · 4010.1007/s41061-020-00302-w ↗
48. Lv · Int. J. Nanomed. · 2022 · 17 · 461910.2147/IJN.S379526 ↗
49. Li · ACS Appl. Mater. Interfaces · 2016 · 8 · 955710.1021/acsami.5b11588 ↗
50. Hu · Oncol. Lett. · 2015 · 10 · 150710.3892/ol.2015.3479 ↗
51. Hu · Int. J. Nanomed. · 2019 · 14 · 736510.2147/IJN.S201358 ↗
52. Shetty · AJR, Am. J. Roentgenol. · 2006 · 187 · 134910.2214/AJR.05.0468 ↗
53. Ye · Adv. Mater. · 2014 · 26 · 667010.1002/adma.201402710 ↗
54. Huynh · Int. J. Mol. Sci. · 2020 · 21 · 517410.3390/ijms21145174 ↗
55. Dou · Chem. Soc. Rev. · 2017 · 46 · 733810.1039/C7CS00418D ↗
56. Xu · Chem. Mater. · 2008 · 20 · 416710.1021/cm8008418 ↗
57. Nguyen · ACS Nano · 2016 · 10 · 214410.1021/acsnano.5b06623 ↗
58. Chen · Nanoscale · 2017 · 9 · 221910.1039/C6NR07656D ↗
59. Lou · J. Nucl. Med. · 2018 · 21 · 121
60. Filetti · Ann. Oncol. · 2019 · 30 · 185610.1093/annonc/mdz400 ↗
61. Pellico · Chem. Soc. Rev. · 2021 · 50 · 335510.1039/D0CS00384K ↗
62. Zhou · Biomaterials · 2015 · 57 · 4110.1016/j.biomaterials.2015.04.013 ↗
63. Zhang · IUBMB Life · 2022 · 74 · 43310.1002/iub.2601 ↗
64. Wu · MedComm · 2020 · 1 · 21110.1002/mco2.31 ↗
65. How · Gynecol. Oncol. · 2015 · 137 · 43610.1016/j.ygyno.2015.04.004 ↗
66. Chen · Front. Endocrinol. · 2021 · 12 · 77417410.3389/fendo.2021.774174 ↗
67. Hillary · Langenbecks Arch. Surg. · 2018 · 403 · 11110.1007/s00423-017-1641-2 ↗
68. Vidal Fortuny · Br. J. Surg. · 2016 · 103 · 53710.1002/bjs.10101 ↗
69. Lu · Analyst · 2015 · 140 · 115510.1039/C4AN01847H ↗
70. Cai · Chem. Soc. Rev. · 2019 · 48 · 2210.1039/C8CS00494C ↗
71. Chen · Chem. Rev. · 2016 · 116 · 282610.1021/acs.chemrev.5b00148 ↗
72. Cheng · ACS Nano · 2017 · 11 · 1227610.1021/acsnano.7b05966 ↗
73. Liu · Chem. Soc. Rev. · 2019 · 48 · 205310.1039/C8CS00618K ↗
74. Knox · Acc. Chem. Res. · 2018 · 51 · 289710.1021/acs.accounts.8b00351 ↗
75. Kunjachan · Chem. Rev. · 2015 · 115 · 1090710.1021/cr500314d ↗
76. Knox · Nat. Commun. · 2017 · 8 · 179410.1038/s41467-017-01951-0 ↗
77. Phan · Sci. Rep. · 2018 · 8 · 880910.1038/s41598-018-27204-8 ↗
78. Wang · Acta Biomater. · 2020 · 102 · 36710.1016/j.actbio.2019.11.043 ↗
79. Choi · Nanoscale Adv. · 2021 · 3 · 71010.1039/D0NA00905A ↗
80. Farzin · Adv. Healthcare Mater. · 2020 · 9 · e190105810.1002/adhm.201901058 ↗
81. Salvador-Morales · ACS Nano · 2022 · 16 · 506210.1021/acsnano.1c10635 ↗
82. Jennings · ACS Nano · 2011 · 5 · 557910.1021/nn201050g ↗
83. Xu · Front. Bioeng. Biotechnol. · 2022 · 10 · 87128510.3389/fbioe.2022.871285 ↗
84. Klostranec · Adv. Mater. · 2006 · 18 · 195310.1002/adma.200500786 ↗
85. Ai · Anal. Biochem. · 2013 · 438 · 2210.1016/j.ab.2013.02.029 ↗
86. Takeyama · Cancer Res. · 1996 · 56 · 1817
87. Fujioka · J. Nanomater. · 2010 · 2010 · 110.1155/2010/937684 ↗
88. Liu · Proc. Natl. Acad. Sci. U. S. A. · 2016 · 113 · 775010.1073/pnas.1605841113 ↗
89. Monopoli · J. Am. Chem. Soc. · 2011 · 133 · 252510.1021/ja107583h ↗
90. Garcia-Vence · Nanomaterials · 2020 · 10 · 237010.3390/nano10122370 ↗
91. Xiao · Int. J. Hyperthermia · 2020 · 37 · 39210.1080/02656736.2020.1752945 ↗
92. Xu · J. Cancer Res. Ther. · 2020 · 16 · 96010.4103/jcrt.JCRT_558_19 ↗
93. Pacini · J. Clin. Endocrinol. Metab. · 2006 · 91 · 92610.1210/jc.2005-1651 ↗
94. Durante · J. Clin. Endocrinol. Metab. · 2006 · 91 · 289210.1210/jc.2005-2838 ↗
95. Zhang · Mol. Med. Rep. · 2015 · 12 · 831310.3892/mmr.2015.4433 ↗
96. 10.1155/2019/168734010.1155/2019/1687340 ↗
97. Wang · Biomater. Sci. · 2019 · 7 · 105210.1039/C8BM01414K ↗
98. Tang · Colloids Surf., B · 2021 · 199 · 11155010.1016/j.colsurfb.2020.111550 ↗
99. Haigh · Cancer · 2001 · 91 · 233510.1002/1097-0142(20010615)91:12<2335::AID-CNCR1266>3.0.CO;2-1 ↗
100. Saini · Mol. Cancer · 2018 · 17 · 15410.1186/s12943-018-0903-0 ↗